RxDoctor Payments Data

Alexi Bellchambers, PA

Physician Assistant · Saint Joseph, MINPI 1881161214

Payments from drug & device makers

$1,350in general payments, 2019–2025

Across 31 payments — averaging $43.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$245
  • Boston Scientific$182
  • E.r. Squibb & Sons, L.L.C.$147
  • Pfizer$126
  • Medtronic$112
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$106
  • plus $432 from 10 others

What the payments were for

  • Food & beverage$1,350100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,350 in reported general payments places this provider in the 75th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$31,568
Medicare patients
302
Services billed
486

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban180$236,354
XareltoRivaroxaban70$88,424
EntrestoSacubitril/Valsartan50$65,605
JardianceEmpagliflozin36$34,985
MultaqDronedarone Hcl23$27,909
Repatha SureclickEvolocumab21$19,592
FarxigaDapagliflozin Propanediol19$11,553
BrilintaTicagrelor11$7,805
Metoprolol Succinate238$4,003
Atorvastatin Calcium235$3,002
Isosorbide Mononitrate ErIsosorbide Mononitrate106$1,915
Flecainide Acetate27$1,822
Ranolazine ErRanolazine25$1,717
Metoprolol Tartrate219$1,598
ClopidogrelClopidogrel Bisulfate89$1,288

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$126$236,354180 claims
Johnson & JohnsonXarelto$27$88,42470 claims
NovartisEntresto$93$65,60550 claims
Boehringer IngelheimJardiance$245$34,98536 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Saint Joseph

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →